![](/img/cover-not-exists.png)
A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure (GOG 9920)
McMeekin, D. Scott, Sill, Michael W., Walker, Joan L., Moore, Kathleen N., Waggoner, Steven E., Thaker, Premal H., Rizack, Tina, Hoffman, James S., Fracasso, Paula M.Volume:
70
Language:
english
Journal:
Obstetrical & Gynecological Survey
DOI:
10.1097/01.ogx.0000471706.11154.3b
Date:
October, 2015
File:
PDF, 88 KB
english, 2015